Mirum Pharmaceuticals, Inc.
Mike Grey has founded several biotechnology companies and is currently chairman or executive chair of Mirum Pharmaceuticals, Amplyx Pharmaceuticals, Curzion Pharmaceuticals, Reneo Pharmaceuticals and Spruce Biosciences. He also serves as venture partner at Pappas Capital. Mike has 45 years of experience in the pharmaceutical and biotechnology industries, and has held senior positions at a number of companies, including Auspex, SGX Trega, BioChem Pharma and Glax. Mike serves on the board of directors of BioMarin Pharmaceutical Inc., Horizon Pharma plc and Mirati Therapeutics, Inc.